Literature DB >> 22050602

Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling.

Joshua E Babiarz1, Morgane Ravon, Sriram Sridhar, Palanikumar Ravindran, Brad Swanson, Hans Bitter, Thomas Weiser, Eric Chiao, Ulrich Certa, Kyle L Kolaja.   

Abstract

To gain insight into the molecular regulation of human heart development, a detailed comparison of the mRNA and miRNA transcriptomes across differentiating human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and biopsies from fetal, adult, and hypertensive human hearts was performed. Gene ontology analysis of the mRNA expression levels of the hiPSCs differentiating into cardiomyocytes revealed 3 distinct groups of genes: pluripotent specific, transitional cardiac specification, and mature cardiomyocyte specific. Hierarchical clustering of the mRNA data revealed that the transcriptome of hiPSC cardiomyocytes largely stabilizes 20 days after initiation of differentiation. Nevertheless, analysis of cells continuously cultured for 120 days indicated that the cardiomyocytes continued to mature toward a more adult-like gene expression pattern. Analysis of cardiomyocyte-specific miRNAs (miR-1, miR-133a/b, and miR-208a/b) revealed an miRNA pattern indicative of stem cell to cardiomyocyte specification. A biostatistitical approach integrated the miRNA and mRNA expression profiles revealing a cardiomyocyte differentiation miRNA network and identified putative mRNAs targeted by multiple miRNAs. Together, these data reveal the miRNA network in human heart development and support the notion that overlapping miRNA networks re-enforce transcriptional control during developmental specification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22050602      PMCID: PMC4048009          DOI: 10.1089/scd.2011.0357

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  49 in total

1.  DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal.

Authors:  Yangming Wang; Rostislav Medvid; Collin Melton; Rudolf Jaenisch; Robert Blelloch
Journal:  Nat Genet       Date:  2007-01-28       Impact factor: 38.330

Review 2.  Embryonic stem cells as a source of models for drug discovery.

Authors:  Colin W Pouton; John M Haynes
Journal:  Nat Rev Drug Discov       Date:  2007-08       Impact factor: 84.694

3.  Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.

Authors:  Ryan D Morin; Michael D O'Connor; Malachi Griffith; Florian Kuchenbauer; Allen Delaney; Anna-Liisa Prabhu; Yongjun Zhao; Helen McDonald; Thomas Zeng; Martin Hirst; Connie J Eaves; Marco A Marra
Journal:  Genome Res       Date:  2008-02-19       Impact factor: 9.043

4.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

5.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

6.  Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

Authors:  Yong Zhao; Joshua F Ransom; Ankang Li; Vasanth Vedantham; Morgan von Drehle; Alecia N Muth; Takatoshi Tsuchihashi; Michael T McManus; Robert J Schwartz; Deepak Srivastava
Journal:  Cell       Date:  2007-03-29       Impact factor: 41.582

7.  Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence.

Authors:  Louise C Laurent; Jing Chen; Igor Ulitsky; Franz-Josef Mueller; Christina Lu; Ron Shamir; Jian-Bing Fan; Jeanne F Loring
Journal:  Stem Cells       Date:  2008-04-10       Impact factor: 6.277

8.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.

Authors:  Lei Yang; Mark H Soonpaa; Eric D Adler; Torsten K Roepke; Steven J Kattman; Marion Kennedy; Els Henckaerts; Kristina Bonham; Geoffrey W Abbott; R Michael Linden; Loren J Field; Gordon M Keller
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

9.  An extended transcriptional network for pluripotency of embryonic stem cells.

Authors:  Jonghwan Kim; Jianlin Chu; Xiaohua Shen; Jianlong Wang; Stuart H Orkin
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

10.  Most Caenorhabditis elegans microRNAs are individually not essential for development or viability.

Authors:  Eric A Miska; Ezequiel Alvarez-Saavedra; Allison L Abbott; Nelson C Lau; Andrew B Hellman; Shannon M McGonagle; David P Bartel; Victor R Ambros; H Robert Horvitz
Journal:  PLoS Genet       Date:  2007-12       Impact factor: 5.917

View more
  39 in total

1.  Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

Authors:  Liang Guo; Sandy Eldridge; Mike Furniss; Jodie Mussio; Myrtle Davis
Journal:  Curr Protoc Chem Biol       Date:  2015-09-01

Review 2.  Stem cells and stem cell-derived tissues and their use in safety assessment.

Authors:  Kyle Kolaja
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 3.  Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?

Authors:  Tarek Magdy; Brian T Burmeister; Paul W Burridge
Journal:  Pharmacol Ther       Date:  2016-09-05       Impact factor: 12.310

4.  Impact of miR-26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non-canonical Wnt signalling.

Authors:  Duo Wang; Chang Liu; Yumei Wang; Wenjing Wang; Kang Wang; Xiujuan Wu; Zhigang Li; Cuimei Zhao; Li Li; Luying Peng
Journal:  Cell Prolif       Date:  2017-08-15       Impact factor: 6.831

5.  The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.

Authors:  Kamal Razavi-Azarkhiavi; Mahmoud Reza Jaafari; Khalil Abnous; Bibi Marjan Razavi; Amir Hossein Jafarian; Faezeh Vahdati Hassani; Kobra Shirani; Gholamreza Karimi
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

6.  Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production.

Authors:  Connie Wu; Pankaj Arora; Obiajulu Agha; Liam A Hurst; Kaitlin Allen; Daniel I Nathan; Dongjian Hu; Pawina Jiramongkolchai; J Gustav Smith; Olle Melander; Sander Trenson; Stefan P Janssens; Ibrahim Domian; Thomas J Wang; Kenneth D Bloch; Emmanuel S Buys; Donald B Bloch; Christopher Newton-Cheh
Journal:  Mol Cell Biol       Date:  2016-06-29       Impact factor: 4.272

7.  Involvement of miR-1 in the protective effect of hydrogen sulfide against cardiomyocyte apoptosis induced by ischemia/reperfusion.

Authors:  Bo Kang; Jiang Hong; Jian Xiao; Xiaoyan Zhu; Xin Ni; Yufeng Zhang; Bin He; Zhinong Wang
Journal:  Mol Biol Rep       Date:  2014-07-10       Impact factor: 2.316

Review 8.  Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.

Authors:  Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

Review 9.  Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.

Authors:  Miguel F Tenreiro; Ana F Louro; Paula M Alves; Margarida Serra
Journal:  NPJ Regen Med       Date:  2021-06-01

10.  In Situ Maturated Early-Stage Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improve Cardiac Function by Enhancing Segmental Contraction in Infarcted Rats.

Authors:  Diogo Biagi; Evelyn Thais Fantozzi; Julliana Carvalho Campos-Oliveira; Marcus Vinicius Naghetini; Antonio Fernando Ribeiro; Sirlene Rodrigues; Isabella Ogusuku; Rubia Vanderlinde; Michelle Lopes Araújo Christie; Debora Bastos Mello; Antonio Carlos Campos de Carvalho; Marcos Valadares; Estela Cruvinel; Rafael Dariolli
Journal:  J Pers Med       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.